New adult inpatient cancer hospital in the Longwood Medical Area by Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn:
“On Wednesday, July 24, 2024, please join Dana-Farber President and CEO Laurie H. Glimcher, MD, Whittier Street Health Center President and CEO Frederica M. Williams, and members of Dana-Farber’s senior leadership team for a discussion on our plan to develop a new adult inpatient cancer hospital in the Longwood Medical Area.
We are excited to share with you our vision for the future of cancer care and we look forward to your input.
Details below. .
RSVP here: [email protected]
8:30 a.m. – 11:00 a.m.
Whittier Street Health Center
Frederica M. Williams Building
1290 Tremont Street, Roxbury, MA 02120.”
Source: Dana-Farber Cancer Institute/LinkedIn
Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a leading institution for cancer treatment and research. It was founded by Sidney Farber on 1947. Currently, the Institute has over 5,000 staff, faculty, and clinicians on board. They manage in excess of 640,000 outpatient visits each year, oversee more than 1,000 hospital discharges annually, and are actively involved in over 1,100 ongoing clinical trials.
As of 2023, Dana-Farber is ranked as the #4 cancer hospital globally. Dana-Farber’s research contributions include the development of Gleevec, a highly successful treatment for chronic myeloid leukemia.